Related Experiment Video

Updated: Jul 1, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

[Plasma interleukin-6 in patients with disseminated intravascular coagulation]

K Minamikawa1, H Wada, M Ohiwa

  • 12nd Department of Internal Medicine, Mie University School of Medicine.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|December 1, 1992
PubMed

Insights

High plasma Interleukin-6 (IL-6) levels indicate immune system activation in patients with disseminated intravascular coagulation (DIC). Elevated IL-6 is linked to multiple organ failure and poor prognosis in DIC patients.

Area of Science:

  • Biochemistry
  • Immunology
  • Pathophysiology

Context:

  • Disseminated intravascular coagulation (DIC) is a complex syndrome with high mortality.
  • Understanding the role of inflammatory markers in DIC is crucial for prognosis.
  • Previous research has explored various biomarkers in DIC, but the specific role of IL-6 requires further elucidation.

Purpose:

  • To investigate the association between plasma Interleukin-6 (IL-6) levels and the clinical status of patients with disseminated intravascular coagulation (DIC).
  • To determine if plasma IL-6 levels correlate with C-reactive protein (CRP) in DIC patients.
  • To explore the potential role of immune system activation in the pathogenesis of DIC and associated organ failure.

Summary:

  • Plasma Interleukin-6 (IL-6) levels were measured in 60 patients diagnosed with disseminated intravascular coagulation (DIC).
  • Significantly elevated plasma IL-6 levels were observed in patients with DIC, with particularly high concentrations noted in those experiencing multiple organ failure (MOF) or presenting with a poor prognosis.
  • While plasma IL-6 correlated positively with C-reactive protein (CRP) in non-DIC patients, this correlation was absent in the DIC cohort.

Impact:

  • The findings suggest that elevated plasma IL-6 is a significant indicator of immune system activation in DIC.
  • Increased IL-6 levels may serve as a prognostic marker for disease severity, including multiple organ failure and poor outcomes in DIC.
  • This research highlights the involvement of immune system pathways in the progression of DIC and the development of organ failure, potentially opening avenues for targeted therapies.

More Related Videos

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo06:23

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...